Royston Ivor
- SEC CIK
- 0001026765
No open-market purchases or sales filed in the past year.
Current role at each company
- VIRX Viracta Therapeutics, Inc.Directoras of Nov 27, 2024
- BIOC Biocept IncDirectoras of Sep 8, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Royston Ivor as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VIRX Viracta Therapeutics, Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 29, 2022 (view filing) | Aug 26 | 3 days | Royston IvorCEO & President | SSale | −13.4K | $4.01 | −$53.6K | −2.1%612.8K after | |
| May 27, 2022 (view filing) | May 26 | 1 day | Royston IvorCEO & President | SSale | −13.2K | $1.90 | −$25.0K | −2.1%600.9K after | |
| Mar 1, 2022 (view filing) | Feb 28 | 1 day | Royston IvorCEO & President | SSale | −14.6K | $2.78 | −$40.7K | −2.4%588.9K after | |
| Nov 29, 2021 (view filing)7:46 PM ET | Nov 26-29 | 3 days | Royston IvorCEO & President | SSale | −27.7K | $4.81 | −$133.5K | −4.6%571.3K after | 2 lots |
| Nov 15, 2021 (view filing) | Nov 15 | Same day | Royston IvorCEO & President | PPurchase | +8.00K | $5.56 | +$44.5K | +1.5%548.6K after |